| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 163520-33-0 | 4,5-Dihydro-5,5-diphenyl-3-isoxazolecarboxylic acid ethyl ester | C18H17NO3 |
| 163521-08-2 | Vilazodone hydrochloride | C26H27N5O2.HCl |
| 163521-09-3 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester hydrochloride | C28H30N4O3.2(HCl) |
| 163521-11-7 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid ethyl ester | C28H30N4O3 |
| 163521-12-8 | Vilazodone | C26H27N5O2 |
| 163521-19-5 | 5-[4-[4-(5-Cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-benzofurancarboxylic acid | C26H26N4O3 |
| 163521-20-8 | Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate | C15H18N2O3 |
| 163556-04-5 | 3,5-Diformyl-1-indolizinecarboxylic acid methyl ester | C12H9NO4 |
| 163558-30-3 | Fmoc-S-sulfo-L-cysteine disodium salt | C18H15NNa2O7S2 |
| 163563-64-2 | 2-Chloro-6-phenylnicotinonitrile | C12H7ClN2 |
| 163564-58-7 | Kadsulignan N | C24H30O7 |
| 163578-99-2 | Poly(tetramethylene-3-methyltetramethylene ether)glycol bis(4-aminobenzoate) | C23H30N2O5 |
| 163596-56-3 | (E)-1-(3-Phenyl-2-propenyl)piperazine dihydrochloride | C13H18N2.2(HCl) |
| 163596-75-6 | 4-Bromo-3-nitrobenzaldehyde | C7H4BrNO3 |
| 163597-57-7 | 3-Cyano-4-isobutyloxythiobenzamide | C12H14N2OS |
| 163619-04-3 | Fmoc-D-Trp(Boc)-OH | C31H30N2O6 |
| 163620-24-4 | 2-(1-Methylhydrazino)-5-(trifluoromethyl)pyridine | C7H8F3N3 |
| 163630-79-3 | 1'-[4-[1-(4-Fluorophenyl)-1H-indol-3-yl]butyl]-spiro[isobenzofuran-1(3H),4'-piperidine] (E)-2-butenedioate (1:1) | C30H31FN2O.C4H4O4 |
| 163630-91-9 | 3-(4-Fluorophenyl)-8-azabicyclo[3.2.1]oct-2-ene | C13H14FN |
| 163631-02-5 | 1-Benzyl-4-(4-fluorophenyl)piperidin-4-ol | C18H20FNO |
| 163634-05-7 | Evofolin C | C14H18O2 |
| 163658-33-1 | (6-Ethylpyridin-2-yl)methanol | C8H11NO |
| 163660-06-8 | Kadsulignan L | C23H26O7 |
| 163660-10-4 | Daphnodorin F | C30H22O10 |
| 163680-77-1 | Pazufloxacin mesilate | C16H15FN2O4.CH4O3S |
| 163685-37-8 | 1-[2-Hydroxy-3-[4-(2-methoxyethyl)phenoxy]propoxy]-3-[(1-methylethyl)amino]-2-propanol | C18H31NO5 |
| 163685-38-9 | 1-[2-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol | C15H25NO3 |
| 163702-01-0 | Oligo[2-hydroxy-2-methyl-1-[4-(1-methylvinyl)phenyl]propanone] | (C13H16O2)n |
| 163702-05-4 | (Perfluorobutoxy)ethane | C6H5F9O |
| 163702-07-6 | Methyl nonafluorobutyl ether | C5H3F9O |
| 163702-08-7 | 1,1,2,3,3,3-Hexafluoro-1-methoxy-2-(trifluoromethyl)propane | C5H3F9O |
| 163706-06-7 | Cangrelor | C17H25Cl2F3N5O12P3S2 |
| 163706-36-3 | Cangrelor tetrasodium | C17H21Cl2F3N5O12P3S2.Na4 |
| 163706-51-2 | 2-[(3,3,3-Trifluoropropyl)thio]adenosine | C13H16F3N5O4S |
| 163706-58-9 | N-[2-(Methylthio)ethyl]-2-[(3,3,3-trifluoropropyl)thio]adenosine | C16H22F3N5O4S2 |
| 163706-61-4 | (Dichloromethylene)bis[phosphonic acid] mono(tributylamine) salt | C12H27N.CH4Cl2O6P2 |
| 163719-78-6 | 5-Ethenyl-1,2,4-oxadiazole-3-carboxylic acid ethyl ester | C7H8N2O3 |
| 163733-96-8 | 3,4,5-Trifluoroaniline | C6H4F3N |
| 163733-98-0 | 2-Amino-3,5-difluorophenol | C6H5F2NO |
| 163733-99-1 | 4-Amino-2,3-difluorophenol | C6H5F2NO |
| 163734-01-8 | 2-Amino-4,5-difluorophenol | C6H5F2NO |
| 163759-49-7 | 2'-O-(2-Methoxyethyl)-5-methyluridine | C13H20N2O7 |
| 163759-50-0 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine | C34H38N2O9 |
| 163759-51-1 | (R)-5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methyluridine 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] | C43H55N4O10P |
| 163759-94-2 | N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-5-methylcytidine 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite] | C50H60N5O10P |
| 163759-97-5 | 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)uridine 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite] | C42H53N4O10P |
| 163765-44-4 | (R)-4-Boc-2-methylpiperazine | C10H20N2O2 |
| 163768-50-1 | Auristatin F | C40H67N5O8 |
| 163769-88-8 | 5,6-Dihydro-2,3-dimethoxy-6,6-dimethylbenz[7,8]indolizino[2,3-b]quinoxaline | C22H21N3O2 |
| 163795-75-3 | SYBR Green I |